Vitenskapelig artikkel

• Margunn Bye Tosdal; Turid Helen Felli Lunde; Tor Audun Hervig et al. (2026). Decreasing Platelet Aggregation Despite Increasing Soluble P-selectin during Pregnancy in Women with and without Heterozygous Factor v Leiden Mutation. (ekstern lenke)
• Carl Michael Baravelli; Sverre Sandberg; Marte Høvik Hammersland et al. (2026). Clinical Characteristics and Outcomes of Acute Intermittent Porphyria: Insights From the European Porphyria Registry. (ekstern lenke)
• Isabel Moreno-Parro; Jorge Díaz-Garzón; Berta Sufrate-Vergara et al. (2026). Thyroid hormone profile and biological variation in a population of athletes during an entire sport season. (ekstern lenke)
• Joakim Hekland; Christine Morken ; Elisabet Eriksson Boija et al. (2025). Diagnostic performance and user-friendliness of five rapid antigen tests for severe acute respiratory syndrome coronavirus 2. (ekstern lenke)
• Grethe Åstrøm Ueland; Tony Ernes; Tone Vonheim Madsen et al. (2024). Women Suffered More Than Men Both During and After the COVID‐19 Pandemic—A Cross‐Sectional Study Among 29,079 Patients With Type 2 Diabetes. (ekstern lenke)
• Christoph Buchta; Rachel Marrington; Barbara De la Salle et al. (2025). Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part III – EQA samples. (ekstern lenke)
• Christoph Buchta; Rachel Marrington; Barbara De la Salle et al. (2025). Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part II – EQA cycles. (ekstern lenke)
• Christoph Buchta; Barbara De la Salle; Rachel Marrington et al. (2025). Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part V – Benefits for stakeholders other than participants. (ekstern lenke)
• Christoph Buchta; Rachel Marrington; Barbara De la Salle et al. (2025). Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part I – EQA in general and EQA programs in particular. (ekstern lenke)
• Paul Kjetel Soldal Lillemoen; Pernille Kjeilen Fauskanger; Sverre Sandberg et al. (2025). Biological Variation of Erythrocyte Total, Metal-Free, and Zinc Protoporphyrin IX in Patients with Erythropoietic Protoporphyria and Healthy Subjects: Implications for Clinical Interpretation and Monitoring. (ekstern lenke)
• W. Greg Miller; Liesbet Deprez; Sverre Sandberg et al. (2026). Demonstrating commutability of an existing certified reference material for use with an end-user measurement procedure that was not included in the original commutability assessment. (ekstern lenke)
• Christoph Buchta; Barbara De la Salle; Rachel Marrington et al. (2025). Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV – Benefits for participant laboratories. (ekstern lenke)
• Matthias Orth; Sverre Sandberg; Patti Shih (2025). Direct-to-Consumer Testing: Benefits and Concerns of Commercially Accessed Laboratory Tests. (ekstern lenke)
• Anne Elisabeth Solsvik; Pernille Kjeilen Fauskanger; Anne Stavelin et al. (2025). A New International Patient-Based External Quality Assessment Program to Monitor Harmonization and Standardization Efforts. (ekstern lenke)
• Aasne Karine Aarsand; Abdurrahman Coşkun; Sverre Sandberg (2025). Utilizing the Stability of Individual Homeostatic Setpoints over Time - A Step Forward on the Path to Personalized Laboratory Medicine. (ekstern lenke)
• Anne Stavelin; Eva Rønneseth; Anne Lise Fossum et al. (2025). Quality assurance using patient split samples: recommendations for primary healthcare laboratories. (ekstern lenke)
• Wytze P. Oosterhuis; Abdurrahman Coskun; Sverre Sandberg et al. (2026). Measurement uncertainty for practical use – applied in hematology. (ekstern lenke)
• Tone Bukve; Sverre Sandberg; Wenche Sletbakk Vie et al. (2019). Commutability of a whole-blood external quality assessment material for point-of-care C-reactive protein, glucose, and hemoglobin testing. (ekstern lenke)
• Anne Lise Bjørke Monsen; Ingrid Kristin Torsvik; Per Magne Ueland et al. (2012). Increased yet iron-restricted erythropoiesis in postpartum mothers. (ekstern lenke)
• Dår Kristian Kur; Elisabet Eriksson Boija; Christine Morken et al. (2025). Analytical performance and user-friendliness of four point-of-care measuring systems for monitoring prothrombin time international normalized ratio in the hands of the intended users. (ekstern lenke)
• Andrea R. Horvath; Sarah J. Lord; Andrew St John et al. (2014). From biomarkers to medical tests: The changing landscape of test evaluation. (ekstern lenke)
• Ann-Helen Kristoffersen; Geir Thue; Sverre Sandberg (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. (ekstern lenke)
• Gunn Berit Berge Kristensen; Kari Nerhus; Geir Thue et al. (2006). Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose. (ekstern lenke)
• Torleif Trydal; Bjørn Bolann; Frank Roger Brosstad et al. (2005). Analyse av protrombintid i primærhelsetjenesten. (ekstern lenke)
• Ann-Helen Kristoffersen; Per Hyltoft Petersen; Line Bjørge et al. (2018). Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women. (ekstern lenke)
• Bjørn Johan Bolann; Geir Thue; Sverre Sandberg (2004). Urine analysis and decision-making on cystitis in general practice. (ekstern lenke)
• Wytze P. Oosterhuis; Hassan Bayat; David Armbruster et al. (2017). The use of error and uncertainty methods in the medical laboratory. (ekstern lenke)
• Erland Hegardt Hall; Marit Holm Sølsnes; Sverre Sandberg et al. (2025). Patient self-management of warfarin therapy – a long-term follow up study. (ekstern lenke)
• Wenche Iren Bjelkarøy; Sverre Sandberg; Geir Thue et al. (2006). Vurdering av urindyppekultur i primærhelsetjenesten. (ekstern lenke)
• Noemie Clouet-Foraison; Santica M. Marcovina; Elena Guerra et al. (2020). Analytical performance specifications for lipoprotein(a), apolipoprotein B-100, and apolipoprotein A-I using the biological variation model in the EuBIVAS population. (ekstern lenke)
• Mette Christophersen Tollånes; Aasne Karine Aarsand; Jørild Haugen Villanger et al. (2012). Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services. (ekstern lenke)
• Geir Thue; Sverre Sandberg (2015). Analytical performance specifications based on how clinicians use laboratory tests. Experiences from a post-analytical external quality assessment programme. (ekstern lenke)
• Aasne K. Aarsand; Per Hyltoft Petersen; Sverre Sandberg (2006). Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. (ekstern lenke)
• Patti Shih; Sverre Sandberg; Jan Balla et al. (2024). Direct-to-consumer testing as consumer initiated testing: compromises to the testing process and opportunities for quality improvement. (ekstern lenke)
• Ann-Helen Kristoffersen; Geir Thue; Eva Ajzner et al. (2012). Interpretation and management of INR results: A case history based survey in 13 countries. (ekstern lenke)
• Una Ørvim Sølvik; Wenche Iren Bjelkarøy; Kari van den Berg et al. (2017). Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. (ekstern lenke)
• Aasne Karine Aarsand; Sverre Sandberg (2014). How to achieve harmonisation of laboratory testing -The complete picture. (ekstern lenke)
• Åsne Bakke; John Cooper; Geir Thue et al. (2017). Type 2 diabetes in general practice in Norway 2005-2015: moderate improvements in risk factor control, but still major gaps in complication screening. (ekstern lenke)
• Aasne K. Aarsand; Helge Boman; Sverre Sandberg (2009). Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. (ekstern lenke)
• Sarah J. Lord; Andrew St John; Patrick M.M. Bossuyt et al. (2019). Setting clinical performance specifications to develop and evaluate biomarkers for clinical use. (ekstern lenke)
• Janice Andersen; Janne Thomsen; Åshild Rostad Enes et al. (2020). Health-related quality of life in porphyria cutanea tarda: A cross-sectional registry based study. (ekstern lenke)
• Giuseppe Lippi; Kathleen Becan-McBride; Darina Behúlová et al. (2013). Preanalytical quality improvement: in quality we trust. (ekstern lenke)
• Una Ørvim Sølvik; Thomas Helge Røraas; Per Hyltoft Petersen et al. (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. (ekstern lenke)
• Abdurrahman Coşkun; Sverre Sandberg; Ibrahim Unsal et al. (2023). Personalized and Population-Based Reference Intervals for 48 Common Clinical Chemistry and Hematology Measurands: A Comparative Study. (ekstern lenke)
• I.N. Norderhaug; Sophie D. Fosså; F. Forland et al. (2003). Health technology assessment and implications for clinical practice: The case of prostate cancer screening. (ekstern lenke)
• Janice Andersen; Karin Nordin; Sverre Sandberg (2016). Illness perception and psychological distress in persons with porphyria cutanea tarda. (ekstern lenke)
• JA Stakkestad; Sverre Sandberg; Kristian S Bjerve et al. (1997). Use and usefullness of laboratory handbooks. (ekstern lenke)
• M Aune; Sverre Sandberg (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. (ekstern lenke)
• Janice Andersen; Eva Gjengedal; Sverre Sandberg et al. (2015). A skin disease, a blood disease or something in between? : an exploratory focus group study of patients' experiences with porphyria cutanea tarda.. (ekstern lenke)
• Abdurrahman Coşkun; Sverre Sandberg; Ibrahim Unsal et al. (2024). Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation Data. (ekstern lenke)
• Liesbet Deprez; Jesper V. Johansen; Thomas Keller et al. (2025). Recommendations for assessing commutability of a replacement batch of a secondary calibrator certified reference material. (ekstern lenke)
• Wagner S. Brum; Nicholas Ashton; Joel Simrén et al. (2023). Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals. (ekstern lenke)
• Jorge Diaz-Garzon; Pilar Fernandez-Calle; Aasne Karine Aarsand et al. (2021). Long-term within- And between-subject biological variation of 29 routine laboratory measurands in athletes. (ekstern lenke)
• Pernille Kjeilen Fauskanger; Sverre Sandberg; Jesper Johansen et al. (2025). Quantification of Difference in Nonselectivity Between In Vitro Diagnostic Medical Devices. (ekstern lenke)
• Helene J. Bustad; Karen Toska; Caroline Schmitt et al. (2019). A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. (ekstern lenke)
• Adil I. Khan; Busadee Pratumvinit; Ellis Jacobs et al. (2023). Point-of-care testing performed by healthcare professionals outside the hospital setting: Consensus based recommendations from the IFCC Committee on Point-of-Care Testing (IFCC C-POCT). (ekstern lenke)
• John Cooper; Tor Claudi; Hrafnkell B Thordarson et al. (2013). Behandlingen av type 1-diabetes i spesialisthelsetjenesten – data fra Norsk diabetesregister for voksne. (ekstern lenke)
• Hatuia Bø Tibelles; Anne Karen Jenum; Lars Johannessen Kirkebøen et al. (2024). High prevalence of retinopathy in young-onset type 2 diabetes and possible sex differences: insights from Norwegian general practice. (ekstern lenke)
• Gunn B.B. Kristensen; Nina Gade Christensen; Geir Thue et al. (2005). Between-lot variation in external quality assessment of glucose: Clinical importance and effect on participant performance evaluation. (ekstern lenke)
• Ann-Helen Kristoffersen; Per Hyltoft Petersen; Sverre Sandberg (2012). A model for calculating the within-subject biological variation and likelihood ratios for analytes with a time-dependent change in concentrations; exemplified with the use of D-dimer in suspected venous thromboembolism in healthy pregnant women. (ekstern lenke)
• Abdurrahman Coşkun; Aasne Karine Aarsand; Sverre Sandberg et al. (2021). Within- And between-subject biological variation data for tumor markers based on the European Biological Variation Study. (ekstern lenke)
• Tone Bukve; Anne Stavelin; Sverre Sandberg (2016). Effect of participating in a quality improvement system over time for point-of-care c-reactive protein, glucose, and hemoglobin testing. (ekstern lenke)
• Wytze P. Oosterhuis; Abdurrahman Coskun; Sverre Sandberg et al. (2023). Performance specifications for sodium should not be based on biological variation. (ekstern lenke)
• Per Hyltoft Petersen; Nina Gade Christensen; Sverre Sandberg et al. (2009). How to deal with semi-quantitative tests? Application of an ordinal scale model to measurements of urine glucose. (ekstern lenke)
• John Cooper; Geir Thue; Tor Claudi et al. (2013). The Norwegian Diabetes Register for Adults –an overview of the first years. (ekstern lenke)
• Carl Michael Baravelli; Aasne Karine Aarsand; Sverre Sandberg et al. (2022). Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study. (ekstern lenke)
• Kjersti Nøkleby; Tore Julsrud Berg; Ibrahimu Mdala et al. (2020). Variation between general practitioners in type 2 diabetes processes of care. (ekstern lenke)
• Thomas Røraas; Sverre Sandberg; Aasne Karine Aarsand et al. (2019). A Bayesian Approach to Biological Variation Analysis. (ekstern lenke)
• A Brock; Sverre Sandberg (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). (ekstern lenke)
• Mette Christophersen Tollånes; Anne-Marte Bakken Kran; Eirik Abildsnes et al. (2020). Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2. (ekstern lenke)
• Ellen van Berkel; Nick Boley; Steve Ellison et al. (2006). Proficiency testing in analytical chemistry, microbiology and laboratory medicine - working group discussions on current status, problems and future directions. (ekstern lenke)
• Signe Flottorp; AD Oxman; JG Cooper et al. (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. (ekstern lenke)
• Signe Flottorp; AD Oxman; JG Cooper et al. (2000). Retningslinjer for diagnostikk og behandling av sår hals. (ekstern lenke)
• Etienne Cavalier; P. Lukas; M. Bottani et al. (2020). European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical .... (ekstern lenke)
• Una Ørvim Sølvik; Aslaug Johanne Risøy; Reidun Lisbet Skeide Kjome et al. (2018). Quality control of Norwegian pharmacy HbA1c testing: a modest beginning. (ekstern lenke)
• Torleif Trydal; Bjørn Johan Bolann; Frank Brosstad et al. (2005). Analyse av protrombintid i primærhelsetjenesten. (ekstern lenke)
• Una Øvrim Sølvik; Anne Stavelin; Nina Gade Christensen et al. (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. (ekstern lenke)
• Janne Cadamuro; Ana-Maria Simundic; Éva Ajzner et al. (2017). A pragmatic approach to sample acceptance and rejection. (ekstern lenke)
• Jenny Foss Abrahamsen; Robert Sothern; Sverre Sandberg et al. (1999). Circadian Variations in Human Peripheral Blood on Days With and Without Bone Marrow Sampling and Relation to Bone Marrow Cell Proliferation. (ekstern lenke)
• AD Oxman; Signe Flottorp; JG Cooper et al. (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. (ekstern lenke)
• TM Eggebo; Eli Smedvig; GF Zanussi et al. (2000). Foster med hydrops hos kvinne fra Vietnam. (ekstern lenke)
• Per Hyltoft Petersen; Sverre Sandberg; CG Fraser et al. (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. (ekstern lenke)
• Gro Gidske; Nina Gade Christensen; Marianne Jevnaker et al. (1998). Resultater fra NOKLUS' utsendelser 1993-97. (ekstern lenke)
• BJ Bolann; Sverre Sandberg (2003). Evaluation of new laboratory tests. (ekstern lenke)
• Per Hyltoft Petersen; L Jørgensen; E Jensen et al. (2003). Er GUM skadelig - eller blot overflødig?. (ekstern lenke)
• M Aune; Sverre Sandberg (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. (ekstern lenke)
• Una Ørvim Sølvik; Thomas Røraas; Per Hyltoft Petersen et al. (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. (ekstern lenke)
• Siri Carlsen; Geir Thue; John Cooper et al. (2015). Benchmarking by HbA1c in a national diabetes quality register - does measurement bias matter?. (ekstern lenke)
• Jenny Foss Abrahamsen; R.B Sothern; Sverre Sandberg et al. (1999). Circadian variations in human peripheral blood on days with and witout bone marrow sampling and relation to bone marroe cell proliferation. (ekstern lenke)
• Una Ørvim Sølvik; Thomas Helge Røraas; Nina Gade Christensen et al. (2013). Diagnosing Diabetes Mellitus: Performance of Hemoglobin A(1c) Point-of-Care Instruments in General Practice Offices. (ekstern lenke)
• Sverre Sandberg (2000). Kan laboratoriesvaret få konsekvenser for pasienten?. (ekstern lenke)
• Bjørn Johan Bolann; Sverre Sandberg (2003). Evaluering av nye laboratorieanalyser. (ekstern lenke)
• Gro Gidske; Sverre Sandberg; Anne Lise Fossum et al. (2022). Point-of-care testing in primary healthcare: a scoring system to determine the frequency of performing internal quality control. (ekstern lenke)
• Caroline Schmitt; Hugo Lenglet; Angèle Yu et al. (2018). Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver. (ekstern lenke)
• Janne Cadamuro; Cornelia Mrazek; Elisabeth Haschke-Becher et al. (2017). To report or not to report: A proposal on how to deal with altered test results in hemolytic samples. (ekstern lenke)
• Anne Stavelin; Berit Oddny Riksheim; Nina Gade Christensen et al. (2016). The importance of reagent lot registration in external quality assurance/proficiency testing schemes. (ekstern lenke)
• Mette Christophersen Tollånes; Geir E. Sjaastad; Bernt Bøgvald Aarli et al. (2020). Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. (ekstern lenke)
• S Skeie; Geir Thue; Sverre Sandberg (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. (ekstern lenke)
• Signe Flottorp; AD Oxman; JG Cooper et al. (2000). Retningslinjer for diagnostikk og behandling av sår hals. (ekstern lenke)
• Gunn Berit Berge Kristensen; Grete Monsen; Svein Skeie et al. (2008). Standardized Evaluation of Nine Instruments for Self-Monitoring of Blood Glucose. (ekstern lenke)
• Aasne Karine Aarsand; Thomas Røraas; Pilar Fernandez-Calle et al. (2017). The biological variation data critical appraisal checklist: A standard for evaluating studies on biological variation. (ekstern lenke)
• Reidun Lisbet Skeide Kjome; Anne Gerd Granås; Kari Nerhus et al. (2010). The Prevalence of Self-Monitoring of Blood Glucose and Costs of Glucometer Strips in a Nationwide Cohort. (ekstern lenke)
• WP Oosterhuis; DE Bruns; J Watine et al. (2004). Evidence-based guidelines in laboratory medicine: Principles and methods. (ekstern lenke)
• Kari Nerhus; Pål Rustad; Sverre Sandberg (2011). Effect of ambient temperature on analytical performance of self-monitoring blood glucose systems. (ekstern lenke)
• Sverre Sandberg; Pernille Kjeilen Fauskanger; Jesper V. Johansen et al. (2023). Recommendations for Setting a Criterion and Assessing Commutability of Sample Materials Used in External Quality Assessment/Proficiency Testing Schemes. (ekstern lenke)
• Carl Michael Baravelli; Sverre Sandberg; Aasne Karine Aarsand et al. (2019). Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: A nationwide cohort study. (ekstern lenke)
• Per Hyltoft Petersen; Nina Gade Christensen; Sverre Sandberg et al. (2008). How to deal with dichotomous tests? Application of a rankit ordinal scale model with examples from the Nordic ordinal scale project on screening tests. (ekstern lenke)
• G Nordin; A Martensson; B Swolin et al. (2004). A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. (ekstern lenke)
• Anh Thi Tran; Tore Julsrud Berg; Bjørn E. Gjelsvik et al. (2019). Ethnic and gender differences in the management of type 2 diabetes: a cross-sectional study from Norwegian general practice.. (ekstern lenke)
• IN Norderhaug; T Wisloff; S Fossa et al. (2004). Prostrate-specific antigen and prostate cancer: General practitioners' and urologists' use of evidence-based information. (ekstern lenke)
• Tone Vonheim Madsen; John Cooper; Siri Carlsen et al. (2023). Intensified follow-up of patients with type 1 diabetes and poor glycaemic control: A multicentre quality improvement collaborative based on data from the Norwegian Diabetes Register for Adults. (ekstern lenke)
• Anne Stavelin; Kristine Flesche; Mette Christophersen Tollånes et al. (2020). Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data. (ekstern lenke)
• Aasne Karine Aarsand; Jorge Díaz-Garzón; Pilar Fernandez-Calle et al. (2018). The EuBIVAS: Within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. (ekstern lenke)
• John Cooper; Åsne Bakke; Ingvild Dalen et al. (2019). Factors associated with glycaemic control in adults with Type 1 diabetes: a registry-based analysis including 7601 individuals from 34 centres in Norway. (ekstern lenke)
• Per Hyltoft Petersen; Flemming Lund; Callum G. Fraser et al. (2018). Valid analytical performance specifications for combined analytical bias and imprecision for the use of common reference intervals. (ekstern lenke)
• Kristin Aakre; Geir Thue; Einar Svarstad et al. (2011). Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care. (ekstern lenke)
• Giulia Cajano; Elena Guerra; Massimo Locatelli et al. (2019). The importance of the Biological Variation Data Critical Appraisal Checklist when designing experimental studies on biological variation. Comparison of two papers reporting biological variation results for S100-β and neuron-specific enolase proteins. (ekstern lenke)
• William A. Bartlett; Federica Braga; Anna Carobene et al. (2015). A checklist for critical appraisal of studies of biological variation. (ekstern lenke)
• Kristin Aakre; Thomas Helge Røraas; Per Hyltoft Petersen et al. (2014). Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. (ekstern lenke)
• Kjersti Tjensvoll; Ove Bruland; Ylva Floderus et al. (2003). Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W. (ekstern lenke)
• Karianne Fjeld Løvaas; John Cooper; Sverre Sandberg et al. (2015). Feasibility of using self-reported patient data in a national diabetes register. (ekstern lenke)
• Per Hyltoft Petersen; Sverre Sandberg; Natàlia Iglesias et al. (2008). 'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV). (ekstern lenke)
• G Hølleland; Sverre Sandberg (1999). Bruk og tolking av serum-kalsiumanalyse. (ekstern lenke)
• Sverre Sandberg; Geir Thue (1999). External quality assurance of test requesting and test interpretation. (ekstern lenke)
• Per Hyltoft Petersen; CG Fraser; Sverre Sandberg et al. (1999). The index of individuality is often a misinterpreted quantity characteristic. (ekstern lenke)
• Anh Thi Tran; Tore Julsrud Berg; Ibrahimu Mdala et al. (2020). Factors associated with potential over- and undertreatment of hyperglycaemia and annual measurement of HbA<inf>1c</inf> in type 2 diabetes in norwegian general practice. (ekstern lenke)
• Mary K. Robinson; Samuel P. Caudill; David D. Koch et al. (2014). Albumin adsorption onto surfaces of urine collection and analysis containers. (ekstern lenke)
• Svein Skeie; Geir Thue; Kari Nerhus et al. (2002). Instruments for self-monitoring of blood-glucose: comparison of testing quality achieved by patients and a technician. (ekstern lenke)
• Mette Christophersen Tollånes; Pål Jenum; Helene Kierkegaard et al. (2021). Evaluation of 32 rapid tests for detection of antibodies against SARS-CoV-2. (ekstern lenke)
• Jenny Foss Abrahamsen; RB Sothern; Sverre Sandberg et al. (1999). Circadian variation in human peripheral blood on days with and without bone marrow sampling and relation to bone marrow proliferation. (ekstern lenke)
• G Holleland; Jørn Schneede; Per Magne Ueland et al. (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. (ekstern lenke)
• Kristina Barbara Slåtsve; Tor Claudi; Knut Tore Lappegård et al. (2021). Factors associated with treatment in primary versus specialist care: A population-based study of people with type 2 and type 1 diabetes. (ekstern lenke)
• Eline A. E van der Hagen; Cas Weykamp; Sverre Sandberg et al. (2021). Feasibility for aggregation of commutable external quality assessment results to evaluate metrological traceability and agreement among results. (ekstern lenke)
• Jordi To-Figueras; Robin Wijngaard; Judit García-Villoria et al. (2021). Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran. (ekstern lenke)
• Kristin M. Aakre; Geir Thue; Sumathi Subramaniam-Håvik et al. (2008). Postanalytical external quality assessment of urine albumin in primary health care: An international survey. (ekstern lenke)
• Jenny A. Doust; Katy J. L. Bell; Mariska M.G. Leeflang et al. (2021). Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection. (ekstern lenke)
• Abdurrahman Coşkun; Sverre Sandberg; Ibrahim Unsal et al. (2021). Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation. (ekstern lenke)
• Lippi Giuseppe; Kathleen Becan-McBride; Darina Behúlová, et al. (2012). Preanalytical quality improvement: in quality we trust. (ekstern lenke)
• Jens Petter Berg; Kristian Folkvord Hanssen; Kristian S Bjerve et al. (2011). Standardisert hemoglobin A1C til diagnostisk bruk?. (ekstern lenke)
• Ann-Helen Kristoffersen; Anne Stavelin; Éva Ajzner et al. (2019). Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM). (ekstern lenke)
• Gro Gidske; Kristin Moberg Aakre; Pål Rustad et al. (2019). Handling of hemolyzed serum samples in clinical chemistry laboratories: The Nordic hemolysis project. (ekstern lenke)
• Anna Carobene; Thomas Røraas; Una Ørvim Sølvik et al. (2017). Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum. (ekstern lenke)
• Graham R.D. Jones; Katy J.L. Bell; Ferruccio Ceriotti et al. (2024). Applying the Milan models to setting analytical performance specifications - Considering all the information. (ekstern lenke)
• Penelope E. Stein; Yonatan Edel; Razan Mansour et al. (2023). Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the European porphyria network. (ekstern lenke)
• George H. Elder; Pauline Harper; Michael Badminton et al. (2013). The incidence of inherited porphyrias in Europe. (ekstern lenke)
• Aslaug Johanne Risøy; Reidun Lisbet Skeide Kjome; Sverre Sandberg et al. (2018). Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes ? A feasibility study. (ekstern lenke)
• Pilar Fernández-Calle; Jorge Díaz-Garzón; William Bartlett et al. (2021). Biological variation estimates of thyroid related measurands - Meta-analysis of BIVAC compliant studies. (ekstern lenke)
• Una Ørvim Sølvik; Elisabet Eriksson Boija; Sara Ekvall et al. (2020). Performance and user-friendliness of the rapid antigen detection tests QuickVue Dipstick Strep A test and DIAQUICK Strep A Blue Dipstick for pharyngotonsillitis caused by Streptococcus pyogenes in primary health care. (ekstern lenke)
• Per Hyltoft Petersen; Sverre Sandberg; Callum G. Fraser (2011). Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus?. (ekstern lenke)
• Jorge Diaz-Garzon; Pilar Fernandez-Calle; Aasne Karine Aarsand et al. (2023). Long-Term Within- and Between-Subject Biological Variation Data of Hematological Parameters in Recreational Endurance Athletes. (ekstern lenke)
• Una Ørvim Sølvik; Elisabeth Sellevoll Løkkebø; Ann-Helen Kristoffersen et al. (2015). Egenkontroll av warfarinbehandling. (ekstern lenke)
• Sverre Sandberg (2000). Kan laboratoriesvaret få konsekvenser for pasienten?. (ekstern lenke)
• Signe Flottorp; AD Oxman; JG Cooper et al. (2000). Retningslinjer for diagnostikk og behandling av sår hals. (ekstern lenke)
• Sverre Sandberg (2000). Nodelling an estimation of measurement error. (ekstern lenke)
• Signe Flottorp; AD Oxman; JG Cooper et al. (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. (ekstern lenke)
• Helene J. Bustad; Marta Vorland; Eva Rønneseth et al. (2013). Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria. (ekstern lenke)
• Signe Flottorp; AD Oxman; JG Cooper et al. (2000). Retningslinjer for diagnostikk og behandling av sår hals. (ekstern lenke)
• Siri Fauli Munkerud; Sverre Grepperud; Sverre Sandberg (2018). Hjemmetjenesten driver omfattende laboratorievirksomhet. (ekstern lenke)
• Aslaug Johanne Risøy; Reidun Lisbet Skeide Kjome; Sverre Sandberg et al. (2023). Diabetes risk assessments and HbA1c-measurements in community pharmacies. (ekstern lenke)
• Rachel Bedenis Forster; Ragnhild Bjarkøy Strandberg; Katrina Louise Bø Tibballs et al. (2022). Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) - a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway. (ekstern lenke)
• Anna Carobene; Elena Guerra; Massimo Locatelli et al. (2018). Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer. (ekstern lenke)
• Anne Stavelin; Per Hyltoft Petersen; Una Ørvim Sølvik et al. (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. (ekstern lenke)
• Mauro Panteghini; Ferruccio Ceriotti; Graham Jones et al. (2017). Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference. (ekstern lenke)
• AD Oxman; Signe Flottorp; JG Cooper et al. (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. (ekstern lenke)
• Per Hyltoft Petersen; Sverre Sandberg; CG Fraser et al. (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. (ekstern lenke)
• A Brock; Sverre Sandberg (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). (ekstern lenke)
• TM Eggebo; E Smedvig; GF Zanussi et al. (2000). Foster med hydrops hos kvinne fra Vietnam. (ekstern lenke)
• Svein Skeie; Geir Thue; Sverre Sandberg (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. (ekstern lenke)
• Ann-Helen Kristoffersen; Éva Ajzner; Dunja Rogic et al. (2016). Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries. (ekstern lenke)
• Gro Gidske; Sverre Sandberg; Pernille Kjeilen Fauskanger et al. (2023). Aggregated data from the same laboratories participating in two glucose external quality assessment schemes show that commutability and transfers of values to control materials are decisive for the biases found. (ekstern lenke)
• Per Hyltoft Petersen; Sverre Sandberg; Nina Gade Christensen et al. (2004). Basic model and preliminary results on a Nordfond project on measurements reported on an ordinal scale. (ekstern lenke)
• Ann-Helen Kristoffersen; Per Hyltoft Petersen; Line Bjørge et al. (2019). Concentration of fibrin monomer in pregnancy and during the postpartum period. (ekstern lenke)
• Laurent Gouya; Paolo Ventura; Manisha Balwani et al. (2019). EXPLORE: A prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks. (ekstern lenke)
• Per Hyltoft Petersen; D Stockl; JO Westgard et al. (2001). Models for combining random and systematic errors, assumptions and consequences for different models. (ekstern lenke)
• Sverre Sandberg; A Brun; O Skadberg et al. (2001). Akutt intermitterende porfyri er en vanskelig diagnose - spesielt hos barn. (ekstern lenke)
• Sverre Sandberg (2001). Analyse av protrombintid i primærhelsetjenesten. (ekstern lenke)
• Sverre Sandberg (2014). Self measurement of glucose – how useful is it and how can it be done. (ekstern lenke)
• Tone Bukve; Thomas Røraas; Berit Oddny Riksheim et al. (2015). Point-of-care urine albumin in general practice offices: Effect of participation in an external quality assurance scheme. (ekstern lenke)
• Øyvind Skadberg; Atle Brun; Sverre Sandberg (2003). Human reticulocytes isolated from peripheral blood: maturation time and hemoglobin synthesis. (ekstern lenke)
• Thomas Røraas; Bård Støve; Per Hyltoft Petersen et al. (2016). Biological variation: The effect of different distributions on estimated within-person variation and reference change values. (ekstern lenke)
• Abdurrahman Coşkun; Anna Carobene; Ozlem Demirelce et al. (2024). Sex-related differences in within-subject biological variation estimates for 22 essential and non-essential amino acids. (ekstern lenke)
• Reyes Serrano Teruel; Geir Thue; Svein Ivar Fylkesnes et al. (2017). Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements?. (ekstern lenke)
• Berna Aslan; Anna Carobene; Niels Jonker et al. (2025). Systematic review and meta-analysis of biological variation data of urine albumin, albumin to creatinine ratio and other markers in urine. (ekstern lenke)
• Reidun Lisbet Skeide Kjome; Kari Nerhus; Sverre Sandberg (2010). Implementation of a method for glucose measurements in community pharmacies. (ekstern lenke)
• Per Hyltoft Petersen; Sverre Sandberg; CG Fraser et al. (2001). Influence of index of individuality on false positives in repeated sampling from healthy individuals. (ekstern lenke)
• Svein Skeie; Geir Thue; Sverre Sandberg (2001). Interpretation of hemaglobin A(1c)(HbA(1c)) values among diabetic patients: implications for quality specifications for HbA(1c). (ekstern lenke)
• Geir Thue; Atle Klovning; Sverre Sandberg (2001). External quality assessment of general practice laboratories: organizational issues and interpretation of feedback reports. (ekstern lenke)
• KJ Skurtveit; Wenche Iren Bjelkarøy; Nina Gade Christensen et al. (2001). Quality of rapid tests for determination of infectious mononucleosis. (ekstern lenke)
• Svein Skeie; Geir Thue; Sverre Sandberg (2001). Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. (ekstern lenke)
• Abdurrahman Coşkun; Anna Carobene; Aasne K. Aarsand et al. (2021). Within- And between-subject biological variation data for serum zinc, copper and selenium obtained from 68 apparently healthy Turkish subjects. (ekstern lenke)
• Ferruccio Ceriotti; Jorge Diaz-Garzon Marco; Pilar Fernandez-Calle et al. (2020). The European Biological Variation Study (EuBIVAS): Weekly biological variation of cardiac troponin i estimated by the use of two different high-sensitivity cardiac troponin i assays. (ekstern lenke)
• Bjørn E. Gjelsvik; Anh Thi Tran; Tore Julsrud Berg et al. (2019). Exploring the relationship between coronary heart disease and type 2 diabetes: a cross-sectional study of secondary prevention among diabetes patients. (ekstern lenke)
• Mette Christophersen Tollånes; Aasne Karine Aarsand; Sverre Sandberg (2011). Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study. (ekstern lenke)
• Atle Brun; H. Steen; Sverre Sandberg (1996). Erythropoietic, protoporphyria: two populations of reticulocytes, with and without protoporphyrin. (ekstern lenke)
• Sverre Sandberg; Nina Gade Christensen; Marianne Jevnaker et al. (1996). Analysekvalitet av hemoglobin og glukose i allmennpraksis. (ekstern lenke)
• Rune Småland; R. Sother; K. Lote et al. (1995). Circadian phase relationship between peripheral blood variables and bone marrow proliferative activity in clinical health. (ekstern lenke)
• Jorge Díaz-Garzón; Pilar Fernandez-Calle; Aasne Karine Aarsand et al. (2020). Increases in High-Sensitivity Cardiac Troponin I in Athletes during a Long-Term Period of Routine Training Out of Competition. (ekstern lenke)
• Siri Carlsen; Torild Skrivarhaug; Geir Thue et al. (2017). Glycemic control and complications in patients with type 1 diabetes – a registry-based longitudinal study of adolescents and young adults. (ekstern lenke)
• Åsne Bakke; Ingvild Dalen; Geir Thue et al. (2019). Variation in the achievement of HbA1c, blood pressure and LDL cholesterol targets in type 2 diabetes in general practice and characteristics associated with risk factor control. (ekstern lenke)
• Rune Småland; RB Sothern; K Lote et al. (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. (ekstern lenke)
• Michela Bottani; Aasne Karine Aarsand; Giuseppe Banfi et al. (2021). European Biological Variation Study (EuBIVAS): Within- And between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants. (ekstern lenke)
• Anne Lise Bjørke Monsen; Roar Gjelsvik; Oddvar Martin Kaarbøe et al. (2008). Riktigere bruk av laboratorietjenester – medisinske aspekter. (ekstern lenke)
• Roar Gjelsvik; Oddvar Martin Kaarbøe; Hanne Husom Haukland et al. (2008). Riktigere bruk av laboratorietjenester – økonomiske aspekter. (ekstern lenke)
• Mira Mykletun; Aasne Karine Aarsand; Egil Støle et al. (2014). Porfyrisykdommer i Norge. (ekstern lenke)
• Thomas Røraas; Bård Støve; Per Hyltoft Petersen et al. (2017). Biological variation: Evaluation of methods for constructing confidence intervals for estimates of within-person biological variation for different distributions of the within-person effect. (ekstern lenke)
• Tze Ping Loh; Sarah J. Lord; Katy Bell et al. (2020). Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing. (ekstern lenke)
• Carmen Ricós; Pilar Fernández-Calle; Elisabet Gonzalez-Lao et al. (2020). Critical appraisal and meta-Analysis of biological variation studies on glycosylated albumin, glucose and HbA<inf>1c</inf>. (ekstern lenke)
• Kjersti Nøkleby; Tore Julsrud Berg; Ibrahimu Mdala et al. (2021). High adherence to recommended diabetes follow-up procedures by general practitioners is associated with lower estimated cardiovascular risk. (ekstern lenke)
• Giuseppe Lippi; Jeffrey J. Chance; Stephen Church et al. (2011). Preanalytical quality improvement: from dream to reality. (ekstern lenke)
• Grethe Åstrøm Ueland; Tony Ernes; Tone Vonheim Madsen et al. (2022). Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes. (ekstern lenke)
• Svein Skeie; C Perich; C Ricos et al. (2005). Postanalytical external quality assessment of blood glucose and hemoglobin A(1c): An international survey. (ekstern lenke)
• Phillip J. Monaghan; Sarah Robinson; Daniel Rajdl et al. (2018). Practical guide for identifying unmet clinical needs for biomarkers. (ekstern lenke)
• Martine J. Hollestelle; Ann-Helen Kristoffersen; René N. Idema et al. (2023). Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands. (ekstern lenke)
• Aasne Karine Aarsand; Per Hyltoft Petersen; Sverre Sandberg (2006). Estimation and Application of Biological Variation of Urinary δ-Aminolevulinic Acid and Porphobilinogen in Healthy Individuals and in Patients with Acute Intermittent Porphyria.. (ekstern lenke)
• J.A Stakkestad; Sverre Sandberg; K.S. Bjerve et al. (1997). Use and usefulnes of laboratory handbooks. (ekstern lenke)
• Sverre Sandberg; K Hellsing; PJ Jørgensen et al. (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. (ekstern lenke)
• Sverre Sandberg (1997). Systematic review of diagnostic tests. (ekstern lenke)
• Sverre Sandberg (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. (ekstern lenke)
• John Cooper; Tor Claudi; Anne Karen Jenum et al. (2009). Quality of Care for Patients With Type 2 Diabetes in Primary Care in Norway Is Improving Results of cross-sectional surveys of 33 general practices in 1995 and 2005. (ekstern lenke)
• Kristin Aakre; Wytze P. Oosterhuis; Sverre Sandberg (2012). How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests?. (ekstern lenke)
• Jorge Diaz-Garzon; Outi Itkonen; Aasne Karine Aarsand et al. (2023). Biological variation of inflammatory and iron metabolism markers in high-endurance recreational athletes; Are these markers useful for athlete monitoring?. (ekstern lenke)
• Anna Carobene; Federica Braga; Thomas Helge Røraas et al. (2013). A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase. (ekstern lenke)
• Aasne Karine Aarsand; Helge Boman; Sverre Sandberg (2009). Familial and sporadic porphyria cutanea tarda: Characterization and diagnostic strategies. (ekstern lenke)
• Per Hyltoft Petersen; Sverre Sandberg; N Iglesias et al. (2008). Opinion Paper: 'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV).. (ekstern lenke)
• Aasne Karine Aarsand; Sverre Sandberg (2005). Porphyrias, a challenge for diagnostic assessment and treatment.. (ekstern lenke)
• Graham R.D. Jones; Aasne Karine Aarsand; Anna Carobene et al. (2024). A New Concept for Reference Change Values—Regression to the Population Mean. (ekstern lenke)
• M Rynning; Sverre Sandberg; M Økland (1997). Etablering av referanseverdier. (ekstern lenke)
• Éva Ajzner; Dunja Rogic; Piet Meijer et al. (2015). An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongation. (ekstern lenke)
• Aasne K. Aarsand; Ann-Helen Kristoffersen; Sverre Sandberg et al. (2021). The European Biological Variation Study (EuBIVAS): Biological Variation Data for Coagulation Markers Estimated by a Bayesian Model. (ekstern lenke)
• Aasne Karine Aarsand; Jørild Haugen Villanger; Egil Støle et al. (2011). European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. (ekstern lenke)
• G Holleland; Jørn Schneede; Per Magne Ueland et al. (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. (ekstern lenke)
• Ann-Helen Kristoffersen; Per Hyltoft Petersen; Thomas Røraas et al. (2017). Estimates of within-subject biological variation of protein c, antithrombin, protein s free, protein s activity, and activated protein c resistance in pregnant women. (ekstern lenke)
• Carl Michael Baravelli; Sverre Sandberg; Aasne Karine Aarsand et al. (2017). Acute hepatic porphyria and cancer risk: a nationwide cohort study. (ekstern lenke)
• Siri Carlsen; Per Hyltoft Petersen; Svein Skeie et al. (2011). Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. (ekstern lenke)
• Andrea R. Horvath; S. J. Lord; Andrew St John et al. (2014). From biomarkers to medical tests: The changing landscape of test evaluation. (ekstern lenke)
• Una Ørvim Sølvik; Per Hyltoft Petersen; Grete Monsen et al. (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. (ekstern lenke)
• Kristin Moberg Aakre; Geir Thue; Sumathi Subramaniam-Håvik et al. (2010). Diagnosing microalbuminuria and consequences for the drug treatment of patients with type 2 diabetes: A European survey in primary care. (ekstern lenke)
• Sverre Sandberg (1997). Systematic review of diagnostic tests. (ekstern lenke)
• JA Stakkestad; Sverre Sandberg; KS Bjerve et al. (1997). Use and usefulnes of laboratory handbooks. (ekstern lenke)
• Anne Stavelin; Per Hyltoft Petersen; Una Øvrim Sølvik et al. (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. (ekstern lenke)
• Andrea Rita Horvath; Patrick M.M. Bossuyt; Sverre Sandberg et al. (2015). Setting analytical performance specifications based on outcome studies - Is it possible?. (ekstern lenke)
• Thomas Helge Røraas; Per Hyltoft Petersen; Sverre Sandberg (2012). Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. (ekstern lenke)
• Sverre Sandberg (1999). Measurement error and laboratory medicine. (ekstern lenke)
• Sverre Sandberg (1999). External quality assurance of test requesting and test interpretations in general practice. A method for developing quality goals from clinicians' opinion and to implement guidelines. (ekstern lenke)
• W. Greg Miller; Thomas Keller; Jeffrey Budd et al. (2023). Recommendations for Setting a Criterion for Assessing Commutability of Secondary Calibrator Certified Reference Materials. (ekstern lenke)
• Anne Stavelin; Sverre Sandberg (2018). Harmonization activities of Noklus - A quality improvement organization for point-of-care laboratory examinations. (ekstern lenke)
• Aasne Karine Aarsand; Thomas Røraas; William A. Bartlett et al. (2018). Harmonization initiatives in the generation, reporting and application of biological variation data. (ekstern lenke)
• Mario Plebani; Janne Cadamuro; Pieter Vermeersch et al. (2024). A vision to the future: Value-based laboratory medicine. (ekstern lenke)
• M Rynning; Sverre Sandberg; M Økland (1997). Etablering av referanseverdier. (ekstern lenke)
• Sverre Sandberg (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. (ekstern lenke)
• Sverre Sandberg; K Hellsing; PJ Jørgensen et al. (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. (ekstern lenke)
• Reidun Lisbet Skeide Kjome; Anne Gerd Granås; Kari Nerhus et al. (2010). Quality assessment of patients’ self-monitoring of blood glucose in community pharmacies. (ekstern lenke)
• Anna Carobene; Marta Strollo; Neils Jonker et al. (2016). Sample collections from healthy volunteers for biological variation estimates' update: A new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. (ekstern lenke)
• Sverre Sandberg; K Hellsing; Per Magnus Jørgensen et al. (1999). Skandinavisk utprøving av laboratorieutstyr for primærhelsetjenesten. Etablering av SKUP og igangsetting av de første evalueringene. (ekstern lenke)
• Sverre Sandberg; Geir Thue (1999). Quality specifications based upon objective analyses based upon clinical needs. (ekstern lenke)
• Sverre Sandberg (1999). Oppslagsbok i laboratoriemedisin. (ekstern lenke)
• Anne Stavelin; Eva Rønneseth; Gro Gidske et al. (2022). Using three external quality assurance schemes to achieve equivalent international normalized ratio results in primary and secondary healthcare. (ekstern lenke)
• Kristina Barbara Slåtsve; Tor Claudi; Knut Tore Lappegård et al. (2020). The total prevalence of diagnosed diabetes and the quality of diabetes care for the adult population in Salten, Norway. (ekstern lenke)
• Anne Elisabeth Solsvik; Ann-Helen Kristoffersen; Sverre Sandberg et al. (2022). A national surveillance program for evaluating new reagent lots in medical laboratories. (ekstern lenke)
• Niels Jonker; Berna Aslan; Beatriz Boned et al. (2021). Critical appraisal and meta-analysis of biological variation estimates for kidney related analytes. (ekstern lenke)
• Sverre Sandberg; Abdurrahman Coskun; Anna Carobene et al. (2024). Analytical performance specifications based on biological variation data – considerations, strengths and limitations. (ekstern lenke)
• William A. Bartlett; Sverre Sandberg; Anna Carobene et al. (2024). A standard to report biological variation data studies - Based on an expert opinion. (ekstern lenke)
• Anna Carobene; Eric Kilpatrick; William A. Bartlett et al. (2024). The biological variation of insulin resistance markers: Data from the European Biological Variation Study (EuBIVAS). (ekstern lenke)
• Sverre Sandberg; W. Oosterhuis; D. Freedman et al. (1997). Systematic reviewing in laboratory medicine. (ekstern lenke)
• Jorge Diaz–Garzon; Pilar Fernandez-Calle; Aasne Karine Aarsand et al. (2021). Biological variation of venous acid-base status measurands in athletes. (ekstern lenke)
• Una Ørvim Sølvik; Elisabeth Sellevoll Løkkebø; Ann-Helen Kristoffersen et al. (2019). Quality of warfarin therapy and quality of life are improved by self-management for two years. (ekstern lenke)
• Séverine L. D. Toussaint; Jasper Ponstein; Mathieu Thoury et al. (2022). Fur glowing under ultraviolet: in situ analysis of porphyrin accumulation in the skin appendages of mammals. (ekstern lenke)
• Brenden Chen; Sharon Whatley; Michael Badminton et al. (2019). International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias. (ekstern lenke)
• Åsne Bakke; Anh Thi Tran; Ingvild Dalen et al. (2018). Population, general practitioner and practice characteristics are associated with screening procedures for microvascular complications in Type 2 diabetes care in Norway. (ekstern lenke)
• Kristina Barbara Slåtsve; Tor Claudi; Knut Tore Lappegård et al. (2022). Level of education is associated with coronary heart disease and chronic kidney disease in individuals with type 2 diabetes: a population-based study. (ekstern lenke)
• Mette Christophersen Tollånes; Anne Karen Jenum; Tore Julsrud Berg et al. (2020). Availability and analytical quality of hemoglobin A1c point-of-care testing in general practitioners’ offices are associated with better glycemic control in type 2 diabetes. (ekstern lenke)
• Anna Carobene; Aasne Karine Aarsand; Elena Guerra et al. (2019). European Biological Variation Study (EuBIVAS): Within- and between-subject biological variation data for 15 frequently measured proteins. (ekstern lenke)
• Aasne Karine Aarsand; Sverre Sandberg (2010). Porfyri: Symptomer - diagnostisering - behandling. (ekstern lenke)
• Carl Michael Baravelli; Aasne Karine Aarsand; Sverre Sandberg et al. (2020). Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study. (ekstern lenke)
• Ibrahimu Mdala; Kjersti Nøkleby; Tore Julsrud Berg et al. (2023). Insulin initiation in patients with type 2 diabetes is often delayed, but access to a diabetes nurse may help—insights from Norwegian general practice. (ekstern lenke)
• Reidun Lisbet Skeide Kjome; Sverre Sandberg; Anne Gerd Granås (2008). Diabetes care in Norwegian pharmacies: a descriptive study. (ekstern lenke)
• J Watine; W Mokaddem; P Carriere et al. (2013). Heterogeneity in the handling of vitamin-K-antagonists and of INR: the example of Quercy-Rouergue. (ekstern lenke)
• Abdurrahman Coşkun; Anna Carobene; Meltem Kilercik et al. (2018). Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects. (ekstern lenke)
• Abdurrahman Coskun; Sverre Sandberg; Ibrahim Unsal et al. (2021). Personalized reference intervals - Statistical approaches and considerations. (ekstern lenke)
• Anh Thi Tran; Åsne Bakke; Tore Julsrud Berg et al. (2018). Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014. (ekstern lenke)
• Anne Stavelin; Piet Meijer; Dianne Kitchen et al. (2012). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. (ekstern lenke)
• Kjersti Nøkleby; Anne Karen Jenum; Esben Selmer Buhl et al. (2024). Effects on HbA1c of referral of type 2 diabetes patients to secondary care. (ekstern lenke)
• Wytze P. Oosterhuis; Sverre Sandberg (2015). Proposal for the modification of the conventional model for establishing performance specifications. (ekstern lenke)
• Outi Itkonen; Niels Jonker; Aasne Karine Aarsand et al. (2024). The European biological variation study (EuBIVAS): Biological variation data for testosterone, follicle stimulating hormone, prolactin, luteinizing hormone and dehydroepiandrosterone sulfate in men. (ekstern lenke)
• Lillan Mo Andreassen; Sverre Sandberg; Gunn Berit Berge Kristensen et al. (2014). Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control. (ekstern lenke)
• Tony Badrick; Graham Jones; W. Greg Miller et al. (2022). Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes. (ekstern lenke)
• Anna Carobene; Irene Marino; Abdurrahman Coskun et al. (2017). The EuBIVAS project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring. (ekstern lenke)
• Giuseppe Lippi; Geoffrey S Baird; Giuseppe Banfi et al. (2017). Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). (ekstern lenke)
• Veronica Sansoni; Giovanni Lombardi; Jorge Díaz–Garzón et al. (2025). Novel biomarkers in bone pathophysiology: Establishing reference intervals and biological variations estimates for serum leptin, sclerostin, lipocalin-2, osteoprotegerin, resistin and Dickkopf-related protein-1 from the European biological variation study (EuBIVAS) populations. (ekstern lenke)
• Una Ørvim Sølvik; John Cooper; Karianne Fjeld Løvaas et al. (2024). A register-based study describing time trends in risk factor control and serious hypoglycaemia together with the effects of starting continuous glucose monitoring in people with type 1 diabetes in Norway. (ekstern lenke)
• Isabel Moreno-Parro; Jorge Diaz-Garzon; Aasne Karine Aarsand et al. (2024). Biological Variation Data in Triathletes for Metabolism and Growth-Related Biomarkers Included in the Athlete Biological Passport. (ekstern lenke)
• Geir Thue; Marianne Jevnaker; Guro- Marte Gulstad et al. (2011). Quality assurance of laboratory work and clinical use of laboratory tests in general practice in Norway: A survey. (ekstern lenke)
• Ann-Helen Kristoffersen; Geir Thue; Sverre Sandberg (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. (ekstern lenke)
• Ellen Økland Blinkenberg; Sverre Sandberg; Vidar Martin Steen et al. (2010). Usefulness of factor V Leiden mutation testing in clinical practice. (ekstern lenke)
• Reidun Lisbet Skeide Kjome; Thomas Helge Røraas; Anne Gerd Granås et al. (2012). Fylkesvise forskjeller i salg av blodglukosestrimler og antidiabetika. (ekstern lenke)
• Tze Ping Loh; Sverre Sandberg; Andrea Rita Horvath (2022). Lot-to-lot reagent verification: Challenges and possible solutions. (ekstern lenke)
• Rune Småland; RB Sothern; K Lote et al. (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. (ekstern lenke)
• Øyvind Skadberg; Sverre Sandberg; Thomas Røraas et al. (2016). The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients. (ekstern lenke)
• Marte Høvik Hammersland; Aasne Karine Aarsand; Sverre Sandberg et al. (2019). Self-efficacy and self-management strategies in acute intermittent porphyria. (ekstern lenke)

Konferanseabstrakt

• Anders Kuvaas Herting; Prabhjot Kour; Sverre Sandberg et al. (2025). 187 Difficulties advising non-native speakers and older adults after point-of-care testing. (ekstern lenke)
• Helene J. Bustad; K Toska; Sverre Sandberg et al. (2013). Searching for pharmacological chaperones aiding to stabilize hydroxymethylbilane synthase. (ekstern lenke)
• Sverre Sandberg (2011). Optimizing porphyria diagnostics with emphasis on pre-analytical, analytical and postanalytical aspects S. Sandberg on behalf of EPNET. (ekstern lenke)
• Janice Andersen; Sverre Sandberg; Målfrid Råheim et al. (2011). Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in minors. (ekstern lenke)
• Sverre Sandberg (2011). POST-ANALYTICAL EXTERNAL QUALITY ASSESSMENT - A WAY TO ASSESS TEST REQUESTING AND INTERPRETATION. (ekstern lenke)
• Helene Bustad Johannessen; E Rxnneseth; Jarl Underhaug et al. (2010). CHARACTERIZATION OF THE MOLECULAR BASIS OF ACUTE INTERMITTENT PORPHYRIA. (ekstern lenke)
• Gunn B.B. Kristensen; Nina Gade Christensen; Geir Thue et al. (2005). Between lot variation in external quality assessment of glucose: Clinical importance and effect on the evaluation of participants' performance. (ekstern lenke)
• R Onody; A Araczki; Svein Skeie et al. (2005). Can we interpret laboratory results correctly?. (ekstern lenke)
• Una Øvrim Sølvik; Anne Stavelin; Nina Gade Christensen et al. (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. (ekstern lenke)
• Sverre Sandberg (2014). POC testing instruments for diagnosing and monitoring diabetes in clinical settings. (ekstern lenke)
• Helene J. Bustad; Eva Rønneseth; Karen Toska et al. (2010). Characterization of the molecular basis of acute intermittent porphyria. (ekstern lenke)

Doktorgradsavhandling

• Helene Bustad Johannessen; Sverre Sandberg (2016). Characterization of Hydroxymethylbilane Synthase and Pharmacological Chaperone Treatment for Acute Intermittent Porphyria. (ekstern lenke)
• Janice Andersen; Sverre Sandberg (2016). A patient-oriented perspective on porphyria. Psychosocial and health-related challenges of acute intermittent porphyria and porphyria cutanea tarda. (ekstern lenke)
• Siri Carlsen; Sverre Sandberg (2016). The use of HbA1c as a quality indicator in diabetes care - analytical and clinical aspects. (ekstern lenke)
• Sverre Sandberg (1982). Porphyrin-induced photodamage at the cellular and the sub- cellular level. (ekstern lenke)
• Lillan Mo Andreassen; Reidun Lisbet Skeide Kjome; Sverre Sandberg et al. (2019). Diabetes in care homes : Special emphasis on medicines and blood glucose measurements. (ekstern lenke)
• Thomas Røraas; Sverre Sandberg (2017). Estimating Biological Variation. Methodological and Statistical Aspects. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Aasne Karine Aarsand; Jordi To-Figueras; Sharon Whatley et al. (2024). Practical recommendations for biochemical and genetic diagnosis of the porphyrias. (ekstern lenke)
• Abdurrahman Coskun; Federica Braga; Anna Carobene et al. (2019). Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters. (ekstern lenke)
• W Greg Miller; David E. Bruns; Glen L Hortin et al. (2009). Current Issues in Measurement and Reporting of Urinary Albumin Excretion. (ekstern lenke)
• Anna Carobene; Aasne Karine Aarsand; William A. Bartlett et al. (2021). The European Biological Variation Study (EuBIVAS): A summary report. (ekstern lenke)
• Sverre Sandberg; Anna Carobene; Bill Bartlett et al. (2022). Biological variation: recent development and future challenges. (ekstern lenke)
• Tze Ping Loh; Alison F. Smith; Katy J.L. Bell et al. (2021). Setting analytical performance specifications using HbA1c as a model measurand. (ekstern lenke)
• Andrea Rita Horvath; Katy J.L. Bell; Ferruccio Ceriotti et al. (2024). Outcome-based analytical performance specifications: current status and future challenges. (ekstern lenke)
• Niels Jonker; Berna Aslan; Beatriz Boned et al. (2020). Critical appraisal and meta-analysis of biological variation estimates for kidney related analytes. (ekstern lenke)
• Anne Stavelin; Sverre Sandberg (2023). Analytical performance specifications and quality assurance of point-of-care testing in primary healthcare. (ekstern lenke)
• Abdurrahman Coskun; Sverre Sandberg; Ibrahim Unsal et al. (2022). Personalized reference intervals: from theory to practice. (ekstern lenke)
• Nathalie Schneider; Kristin Moberg Aakre; Geir Thue et al. (2009). Evaluation of prescription and interpretation of microalbuminuria by general practitioners. (ekstern lenke)
• Gunn Berit Berge Kristensen; Sverre Sandberg (2010). Self-monitoring of blood glucose with a focus on analytical quality: an overview. (ekstern lenke)
• Helene J. Bustad; Juha Pekka Kallio; Marta Vorland et al. (2021). Acute intermittent porphyria: An overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators. (ekstern lenke)
• Ferruccio Ceriotti; Pilar Fernandez-Calle; George G. Klee et al. (2017). Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. (ekstern lenke)
• Kristin Aakre; Joseph Watine; Peter S. Bunting et al. (2012). Self-monitoring of blood glucose in patients with diabetes who do not use insulinuare guidelines evidence-based?. (ekstern lenke)
• Gunn Berit Berge Kristensen; Kristin Aakre; Ann-Helen Kristoffersen et al. (2014). How to conduct External Quality Assessment Schemes for the pre-analytical phase?. (ekstern lenke)
• Anne Stavelin; Sverre Sandberg (2017). Essential aspects of external quality assurance for point-of-care testing. (ekstern lenke)
• Rosy Tirimacco; George Koumantakis; Rajiv Erasmus et al. (2013). Glucose meters - fit for clinical purpose. (ekstern lenke)
• Carmen Ricós; Pilar Fernández-Calle; Elisabet Gonzalez-Lao et al. (2020). Evaluación crítica y meta-Análisis de estudios de variación biológica para albúmina glicosilada, glucosa y HbA<inf>1c</inf>. (ekstern lenke)
• S.J. Lord; A.R. Horvath; Sverre Sandberg et al. (2025). Is this test fit-for-purpose? Principles and a checklist for evaluating the clinical performance of a test in the new era of in vitro diagnostic (IVD) regulation. (ekstern lenke)
• Elisabet González-Lao; Zoraida Corte; Margarita Simón et al. (2019). Systematic review of the biological variation data for diabetes related analytes. (ekstern lenke)
• Michael N. Badminton; Karl E. Anderson; Jean-Charles Deybach et al. (2024). From chemistry to genomics: A concise history of the porphyrias. (ekstern lenke)
• Fernando Marques-Garcia; Beatriz Boned; Elisabet González-Lao et al. (2022). Critical review and meta-analysis of biological variation estimates for tumor markers. (ekstern lenke)
• Jorge Díaz-Garzón; Pilar Fernández-Calle; Joana Minchinela et al. (2019). Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC). (ekstern lenke)
• Jorge Díaz-Garzón; Pilar Fernandez-Calle; Sverre Sandberg et al. (2021). Biological variation of cardiac troponins in health and disease: A systematic review and meta-analysis. (ekstern lenke)

Masteroppgave

• Anne Elisabeth Solsvik; Sverre Sandberg; Marthe W. Aune (2009). Postanalytisk kvalitetssikring i hematologi. Hvordan brukes informasjon fra ulike hematologisystemer?. (ekstern lenke)

Lederartikkel

• Sverre Sandberg; Tomas Zima; Mauro Panteghini (2024). Analytical performance specifications - moving from models to practical recommendations. (ekstern lenke)
• Mauro Panteghini; Sverre Sandberg (2015). Defining analytical performance specifications 15 years after the Stockholm conference. (ekstern lenke)
• Sverre Sandberg; Callum G. Fraser; Andrea Rita Horvath et al. (2015). Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. (ekstern lenke)
• Sverre Sandberg; Anna Carobene; Aasne Karine Aarsand (2022). Biological variation - eight years after the 1st Strategic Conference of EFLM. (ekstern lenke)
• Sverre Sandberg (2001). Nasjonalt Kompetansesenter for porfyrisykdommer. (ekstern lenke)
• Sverre Sandberg; A Brock (2000). Porphyrins and Porphyrias. (ekstern lenke)
• Kristin Moberg Aakre; Sverre Sandberg (2010). Can changes in troponin results be useful in diagnosing myocardial infarction?. (ekstern lenke)
• Aasne Karine Aarsand; Thomas Røraas; Sverre Sandberg (2015). Biological variation-reliable data is essential. (ekstern lenke)
• Mauro Panteghini; Sverre Sandberg (2016). Total error vs. measurement uncertainty: The match continues. (ekstern lenke)

Leserbrev

• Erna Lenters-Westra; Thomas Røraas; Roger K. Schindhelm et al. (2014). Biological Variation of Hemoglobin A1c: Consequences for Diagnosing Diabetes Mellitus. (ekstern lenke)
• Roar Gjelsvik; Oddvar Martin Kaarbøe; Hanne Husom Haukland et al. (2008). Hvordan kan bruk av laboratorietjenester styres?. (ekstern lenke)
• Anna Carobene; Elena Guerra; Massimo Locatelli et al. (2018). Providing Correct Estimates of Biological Variation—Not an Easy Task. The Example of S100-β Protein and Neuron-Specific Enolase. (ekstern lenke)
• Mauro Panteghini; Khosrow Adeli; Ferruccio Ceriotti et al. (2017). American liver guidelines and cutoffs for "normal" ALT: A potential for overdiagnosis. (ekstern lenke)
• Gunn Berit Berge Kristensen; Kari Nerhus; Geir Thue et al. (2004). Standardized evaluation of instruments for self-monitoring of blood glucose by patiens and a technologist. (ekstern lenke)
• Sverre Sandberg; Janecke Thesen; Gisle Roksund et al. (2010). Medisinsk utstyr på legekontor bør kvalitetssikres :. (ekstern lenke)
• Sofie K Van Houcke; Pål Rustad; Hedwig Stepman et al. (2012). Calcium, Magnesium, Albumin, and Total Protein Measurement in Serum as Assessed with 20 Fresh-Frozen Single-Donation Sera. (ekstern lenke)
• Philip Richard Webber; Aasne Karine Aarsand; Arne Kristian Sandvik et al. (2010). Acute porphyrias may be overlooked in patients taking methenamine hippurate. (ekstern lenke)
• Anna Carobene; Elisabet Gonzalez Lao; Margarita Simón et al. (2021). Biological variation of serum insulin: Updated estimates from the European Biological Variation Study (EuBIVAS) and meta-analysis. (ekstern lenke)
• Una Øvrim Sølvik; Anne Stavelin; Nina Gade Christensen et al. (2007). Response to Kitchen et al.'s external quality assessment of prothrombin time: The split-sample model compared to external quality assessment with commercial control material. (ekstern lenke)
• Anna Carobene; Elena Guerra; Fernando Marqués-García et al. (2020). Biological variation of morning serum cortisol: Updated estimates from the European biological variation study (EuBIVAS) and meta-analysis. (ekstern lenke)
• Kristin Aakre; Thomas Helge Røraas; Per Hyltoft Petersen et al. (2013). Week-to-Week Biological Variation in the N-terminal Prohormone of Brain Natriuretic Peptide in Hemodialysis Patients and Healthy Individuals. (ekstern lenke)
• Lutz Schwettmann; Jens Petter Berg; Sverre Sandberg (2018). HbA1c skal angis i mmol/mol. (ekstern lenke)
• Una Ørvim Sølvik; Marianne Risa; Camilla Eide Jacobsen et al. (2015). Performance of 10 systems for self-monitoring of blood glucose by trained healthcare professionals and in the hands of the users. (ekstern lenke)
• Gro Gidske; Una Ørvim Sølvik; Sverre Sandberg et al. (2018). Hemolysis interference studies: Freeze method should be used in the preparation of hemolyzed samples. (ekstern lenke)
• Abdurrahman Coskun; Sverre Sandberg; Ibrahim Unsal et al. (2022). Personalized reference intervals: Using estimates of within-subject or within-person biological variation requires different statistical approaches. (ekstern lenke)
• Ann-Helen Kristoffersen; Eva Ajzner; Josep Miquel Bauça et al. (2017). Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments. (ekstern lenke)
• Anna Carobene; Aasne Karine Aarsand; Abdurrahman Coşkun et al. (2022). Biological variation of serum iron from the European biological variation study (EuBIVAS). (ekstern lenke)
• Abdurrahman Coşkun; Aasne Karine Aarsand; Federica Braga et al. (2021). Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of serum Zinc, Copper and Selenium. (ekstern lenke)
• Martine J. Hollestelle; Ann-Helen Kristoffersen; René N. Idema et al. (2025). Short-term biological variation of coagulation and fibrinolytic measurands. (ekstern lenke)

Vitenskapelig bokkapittel

• Sverre Sandberg (2000). De forundelige porfyrier - en utfordring for diagnostikk og behandling. (ekstern lenke)
• Sverre Sandberg (2000). De forundelige porfyrier - en utfordring for diagnostikk og behandling. (ekstern lenke)
• Atle Klovning; Sverre Sandberg (2003). Searching the Literature and Relevant databases. (ekstern lenke)
• Aasne Karine Aarsand; D Alter; SJ Frost et al. (2006). Diagnosis and management of diabetes mellitus. (ekstern lenke)
• Janice Andersen; Sverre Sandberg; Målfrid Råheim et al. (2011). Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in Norwegian minors. (ekstern lenke)
• Atle Klovning; Sverre Sandberg (2007). Searching the Literature and Relevant databases. (ekstern lenke)
• Anne Karin Aarsand; D Alter; SJ Frost et al. (2007). Diagnosis and Management of Diabetes Mellitus. (ekstern lenke)

Fremhevet artikkel i media

• Sverre Sandberg (2000). Modelling an estimation of measurement error. Michele Neuilly, Lavoisier Publishing, Paris, 1999. No. of pages: x+694. Price: £119.50. ISBN 1-898298-59-9. (ekstern lenke)
• Sverre Sandberg; A Brock (2000). Porphyrins and Porphyrias. (ekstern lenke)
• Matthias Orth; Erik Vollebregt; Tomaso Trenti et al. (2023). Direct-To-consumer laboratory testing (DTCT): Challenges and implications for specialists in laboratory medicine. (ekstern lenke)

Fagbok

• V Helander; Sverre Sandberg (1997). Festskrift til Krister Stàhlberg 50 år. (ekstern lenke)
• Nina Gade Christensen; G Monsen; Sverre Sandberg (1997). Utprøving av analyseinstrumenter. En veiledning spesielt beregnet for utprøving av instrumenter for primærhelsetjenesten. (ekstern lenke)
• Nina Gade Christensen; G Monsen; Sverre Sandberg (1997). Utprøving av analyseinstrumenter. En veiledning spesielt beregnet for utprøving av instrumenter for primærhelsetjenesten. (ekstern lenke)
• R. Kendall; Sverre Sandberg; G. dOnofrio et al. (1996). Reticulocytes: Methods and clinical applications. (ekstern lenke)

Konferanseposter

• Reidun Lisbet Skeide Kjome; Anne Gerd Granås; Kari Nerhus et al. (2007). Control of Self-Monitoring of Blood Glucose in Community Pharmacies. (ekstern lenke)
• Aslaug Johanne Risøy; Reidun Lisbet Skeide Kjome; Sverre Sandberg et al. (2016). A feasibility study for risk assessment ofType 2 Diabetes (T2D) in pharmacies. (ekstern lenke)
• Anh Thi Tran; Bjørn E. Gjelsvik; Tore Julsrud Berg et al. (2018). The influences of ethnicity on the quality of type 2 diabetes care in Norwegian general practice. (ekstern lenke)
• Åsne Bakke; John Cooper; Geir Thue et al. (2017). Type 2 Diabetes in General Practice in Norway 2005-2014: Moderate improvements in risk factor control but still major gaps in complication screening.. (ekstern lenke)

Forskningsrapport

• Oddvar Martin Kaarbøe; Roar Gjelsvik; Sverre Sandberg et al. (2005). Riktigere bruk av laboratorietjenester. (ekstern lenke)

Kapittel i fagbok

• Steinar Hunskaar; Guri Rørtveit; Jørund Straand et al. (2013). Allmennmedisinske rammer og arbeidsteknikker (kap 1.2). (ekstern lenke)
• Aasne Karine Aarsand; Sverre Sandberg (2011). Utredning av porfyrisykdommer. (ekstern lenke)

Rettelse i tidsskrift

• Outi Itkonen; Niels Jonker; Aasne Karine Aarsand et al. (2024). Corrigendum to “The European biological variation study (EuBIVAS): Biological variation data for testosterone, follicle stimulating hormone, prolactin, luteinizing hormone and dehydroepiandrosterone sulfate in men” [Clin. Chim. Acta 555 (2024) 117806] (Clinica Chimica Acta (2024) 555, (S0009898124000470), (10.1016/j.cca.2024.117806)). (ekstern lenke)
• Carl Michael Baravelli; Aasne Karine Aarsand; Sverre Sandberg et al. (2022). Correction: Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study (Orphanet Journal of Rare Diseases, (2022), 17, 1, (72), 10.1186/s13023-022-02201-3). (ekstern lenke)

Konferanseforedrag

• Reidun Lisbet Skeide Kjome; Anne Gerd Granås; Kari Nerhus et al. (2007). Control of patients' glucometers and SMBG technique in community pharmacies. (ekstern lenke)
• Åsne Bakke; John Cooper; Geir Thue et al. (2017). Type 2 diabetes in General Practice in Norway 2005-2014: Moderate improvements in risk Control but still major gaps in complication screening. (ekstern lenke)
• Per Hyltoft Petersen; Sverre Sandberg; Nina Gade Christensen (2006). How to deal with qualitative tests? Principles. (ekstern lenke)
• Bjørn Johan Bolann; Geir Thue; Sverre Sandberg (2004). Hvordan bruker legene urinstrimmelen til diagnostikk av UVI?. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.